ArticleBMC cancer2026
Lived experience of having lymphedema after treatment of head and neck cancer: a qualitative study.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHead and neck lymphedema (HNL) is an accumulation of interstitial protein-rich fluid. During treatment for head and neck cancer (HNC), lymphatic vessels may be removed or damaged, causing a decrease in the function of the lymphatic system among 75% of the patients. This study aimed to explore the lived experience of patients with head and neck lymphedema as a residual symptom after head and neck cancer treatment.
methodsWe performed a qualitative study using a narrative approach. Participants were eligible when they had lymphedema after completed curative HNC treatment. The interviews were analyzed using thematic analysis according to Braun et al. A convenience sampling strategy was used to include a diverse group of participants.
resultsTen participants, five men and five women, were interviewed. Three main themes emerged. “One of many issues” highlighted the difficulty participants faced in distinguishing lymphedema from other symptoms they experienced. The second theme “Having lymphedema & dealing with it,” covers how the participants described their lymphedema and its impact on their social life. The third theme “Knowing and controlling my lymphedema,” covered the participants’ ability to recognize and manage their lymphedema, including self-management.
conclusionsOur study shows that lymphedema is part of a larger palette of residual symptoms after HNC treatment. While it took some time to adjust to having lymphedema, it has minimal impact on social aspects in this sample. Participants showed high therapy compliance and used self-management techniques effectively. Our findings also emphasize the need for healthcare professionals to recognize the interdependence between lymphedema and other residual symptoms and address them in an integrated manner.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.